The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies

Paul Jones, Nancy Kline Leidy, Asha Hareendran, Rosa Lamarca, Ferran Chuecos, Esther García Gil

Respiratory Research · 2016 · 20 citations · 18 references

DOIFull text

Open access

Abstract

ATTAIN (ClinicalTrials.gov identifier: NCT01001494 ) and AUGMENT COPD I (ClinicalTrials.gov identifier: NCT01437397 ).

References

18